GGrantIndex
Sort

172,184 grants matching inflammation

Engineering Tregs for autoimmune diabetes therapy

$2,249,376
Brian T Fife · University Of Minnesota · R01 · FY2025 · DK

Exosomes as mediators of cardiac injury and repair

$2,249,182
Raj Kishore · Temple Univ Of The Commonwealth · P01 · FY2021 · HL

GEARs Combining advances in Genomics and Environmental science to accelerate Actionable Research and practice in ASD

$2,248,581
Heather E Volk · Johns Hopkins University · R01 · FY2024 · ES

Improving Cardiac Function After Myocardial Infarction

$2,247,732
Steven R Houser · Temple Univ Of The Commonwealth · P01 · FY2014 · HL

Cell Signaling of Host Defense

$2,247,646
Michael B Fessler · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES

Allergic sensitization through the airway

$2,246,571
Donald N Cook · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES

IBD: Role of Genetic and Immunopathologic Mechanisms

$2,246,141
Stephan R. Targan · Cedars-Sinai Medical Center · P01 · FY2016 · DK

Center for Lung Biology and Disease

$2,246,019
Samithamby Jeyaseelan · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2021 · GM

Signal Transduction in Atherosclerosis

$2,245,959
University Of Pennsylvania · P01 · FY2005 · HL

In vivo proton MRS studies:cerebral injury in HIV infection

$2,245,305
Bradford A Navia · Tufts University Boston · R01 · FY2008 · NS

Immunovascular interactions in postoperative delirium superimposed on dementia (DSD).

$2,244,681
Niccolo Terrando · Duke University · RF1 · FY2022 · AG

Cell surface proteolysis in development, tissue repair, and malignancy

$2,244,204
Thomas H Bugge · National Institute Of Dental & Craniofacial Research · ZIA · FY2020 · DE

Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.

$2,243,861
Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2024 · AG

Hyaluronan Matrices in Vascular Pathologies

$2,243,684
Vincent C. Hascall · Cleveland Clinic Lerner Com-Cwru · P01 · FY2017 · HL

Mechanisms of Ethnic/Racial Differences in Lung Cancer Due to Cigarette Smoking

$2,243,527
Stephen S Hecht · University Of Minnesota · P01 · FY2022 · CA

University of Texas Southwestern Medical Center SPORE in Kidney Cancer

$2,243,520
James Brugarolas · Ut Southwestern Medical Center · P50 · FY2024 · CA

Identification of TLR signaling network

$2,242,952
Attagene, Inc. · U01 · FY2005 · AI

Early Life Stress Induced Mechanisms of Cardiovascular Disease Risk and Resilience

$2,242,725
Jennifer S Pollock · University Of Alabama At Birmingham · P01 · FY2023 · HL

Pathobiology of Macrovascular Disease in Diabetes

$2,242,721
Alan Chait · University Of Washington · P01 · FY2008 · HL

ENDOTHELIN CONTROL OF RENAL HEMODYNAMIC AND EXCRETORY FUNCTION

$2,242,511
David M Pollock · Augusta University · P01 · FY2012 · HL

COBRE in Digestive & Liver Disease

$2,242,500
Stephen A Duncan · Medical University Of South Carolina · P20 · FY2023 · GM

COBRE in Digestive & Liver Disease

$2,242,500
Stephen A Duncan · Medical University Of South Carolina · P20 · FY2021 · GM

COBRE in Digestive & Liver Disease

$2,242,500
Stephen A Duncan · Medical University Of South Carolina · P20 · FY2020 · GM

COBRE in Digestive & Liver Disease

$2,242,500
Stephen A Duncan · Medical University Of South Carolina · P20 · FY2022 · GM

COBRE in Digestive & Liver Disease

$2,242,497
Stephen A Duncan · Medical University Of South Carolina · P20 · FY2024 · GM